Search Results - "Patocskai, M"

The influence of antioxidants on the oxidative stress of red blood cells by Varga, S I, Novák, Z, Pataki, L, Patocskai, M, Matkovics, B

Get more information

The effects of pesticides on monoaminergic system related to periodic activity of mussels ( Anodonta cygnea L.) by Nemcsók, J., Hiripi, L., Patocskai, M., Salánki, J., Kufcsák, O.

“…1. 1. The effect of a herbicide (paraquat) and an insecticide (methidation) on the periodic activity of mussel in relation to serotonin and dopamine levels and…”
Get full text

Brugada Syndrome: Clinical, Genetic, Molecular, Cellular, and Ionic Aspects by Antzelevitch, Charles, PhD, FACC, FAHA, FHRS, Patocskai, Bence, MD

“…Abstract Brugada syndrome (BrS) is an inherited cardiac arrhythmia syndrome first described as a new clinical entity in 1992. Electrocardiographically…”
Get full text

Mechanisms Underlying Epicardial Radiofrequency Ablation to Suppress Arrhythmogenesis in Experimental Models of Brugada Syndrome by Patocskai, Bence, MD, Yoon, Namsik, MD, Antzelevitch, Charles, PhD

“…Abstract Objectives This study sought to test the hypothesis that elimination of sites of abnormal repolarization, via epicardial radio frequency ablation…”
Get full text

Cellular and ionic mechanisms underlying the effects of cilostazol, milrinone, and isoproterenol to suppress arrhythmogenesis in an experimental model of early repolarization syndrome by Patocskai, Bence, MD, Barajas-Martinez, Hector, PhD, FHRS, Hu, Dan, MD, PhD, FHRS, Gurabi, Zsolt, MD, Koncz, István, MD, PhD, Antzelevitch, Charles, PhD, FHRS

“…Background Early repolarization syndrome (ERS) is associated with polymorphic ventricular tachycardia (PVT) and ventricular fibrillation, leading to sudden…”
Get full text

Effect of antioxidants on the oxidative stress of red blood cells by Varga, I S, Novák, Z, Matkovics, B, Patocskai, M

“…Antioxidant nomination covers a substance group of great variety, therefore, the determination of action mechanism of new antioxidants requires a complicated…”
Get more information

Epirubicin plus Cyclophosphamide followed by Docetaxel plus Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5 by Smith, John W., MD, Buyse, Marc E., ScD, Rastogi, Priya, MD, Geyer, Charles E., MD, Jacobs, Samuel A., MD, Patocskai, Erica J., MD, Robidoux, André, MD, Conlin, Alison K., MD, Ansari, Bilal, MD, Keogh, George P., MD, Stella, Philip J., MD, Gross, Howard M., MD, Lord, Raymond S., MD, Polikoff, Jonathan A., MD, Mauquoi, Celine, MSc, Mamounas, Eleftherios P., MD, Swain, Sandra M., MD, Wolmark, Norman, MD

“…Abstract Background The purpose of this study was to determine the cardiac safety and clinical activity of trastuzumab and bevacizumab with docetaxel following…”
Get full text